Option Care Health (NASDAQ: OPCH) Goes Private in $5.8 Billion Acquisition by McKesson and CD&R

• Option Care Health Acquisition: Option Care Health (NASDAQ: OPCH) is being taken private by McKesson (NYSE: MCK) and CD&R for $32.05 per share.
• Market Premium & Analyst Outlook: The offer represents a 37% premium over its Oct. 5 closing price, with Jefferies Financial Group (NYSE: JEF) downgrading the stock to Hold.
• Deal Valuation & Timeline: The healthcare acquisition is valued at approximately $5.8 billion and is expected to close in the first half of 2027, pending approvals.

Option Care Health (NASDAQ: OPCH), a provider of infusion treatments at home and other care sites, is the company that McKesson (NYSE: MCK) and private equity firm Clayton, Dubilier & Rice (CD&R) have agreed to take private for $32.05 per share in cash.

Jefferies Financial Group (NYSE: JEF) sets a $32.05 price target for Option Care Health, about 3.4% above its $31.00 share price at the time of publication. As highlighted by TheFly, Jefferies downgrades the stock from Buy to Hold. Its target now matches the agreed purchase price.

The offer is roughly 37% above Option Care Health’s Oct. 5 closing price of $23.37. Shares trade at $31.00, up $7.63, or 32.65%, but remain $1.05 below the offer. That gap reflects the risk that the deal may not close; shareholders receive the full $32.05 only if it does.

As highlighted by Business Wire, the deal values Option Care Health at approximately $5.8 billion, including debt. If it closes, CD&R will own 51% and McKesson will own 49%. Closing is expected in the first half of 2027 and remains subject to shareholder and regulatory approvals.